1 min read
Add as a preferred source on GoogleReplimune Posts 54-Cent Q2 GAAP Loss, Beats Estimate by 21 Cents
Cash and cash equivalents totaled $307.8 million on Sept. 30, 2026; the March 31 balance included short-term investments.
Replimune Group, Inc. posted a second-quarter GAAP loss of 54 cents per share, beating the estimate by 21 cents.
Cash and cash equivalents totaled $307.8 million as of Sept. 30, 2026. As of March 31, 2026, the company had $268.9 million in cash, cash equivalents and short-term investments. The reported totals cover different asset categories.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.